• 1
    Osteen RT, Cady B, Chmiel JS, Clive RE, Doggett RLS, Friedman MA, et al. 1991 National survey of carcinoma of the breast by the commission on cancer. J Am Coll Surg 1994; 178:213-9.
  • 2
    Newcomb PA, Lantz PM. Recent trends in breast cancer incidence, mortality, and mammography. Breast Cancer Res Treat 1993; 28:97-106.
  • 3
    Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63:181-7.
  • 4
    Gloeckler-Ries LA, Henson DE, Harras A. Survival from breast cancer according to tumor size and nodal status. Surg Oncol Clin N Am 1994; 3:35-53.
  • 5
    Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996;131:301-8.
  • 6
    Cady B. Traditional and future management of nonpalpable breast cancer. Am Surg 1997; 63:55-8.
  • 7
    National Institutes of Health Consensus Development Panel. Consensus statement: treatment of early-stage breast cancer. Monogr Natl Cancer Inst 1992; 11:1-5.
  • 8
    NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA 1991; 265:391-5.
  • 9
    Seidman JD, Schnaper LA, Aisner SC. Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastasis. Cancer 1995; 75:65-71.
  • 10
    Silverstein MJ, Gierson ED, Waisman JR, Colburn WJ, Gamagami P. Predicting axillary node positivity in patients with invasive carcinoma of the breast by using a combination of T category and palpability. J Am Coll Surg 1995; 180:700-4.
  • 11
    Halverson KJ, Taylor ME, Perez CA, Garcia DM, Myerson R, Philpott G, et al. Management of the axilla in patients with breast cancers one centimeter or smaller. Am J Clin Oncol 1994; 17:461-6.
  • 12
    Ciatto S, Del Turco MR, Bonardi R, Cataliotti L, Distante V, Cardona G, et al. Non-palpable lesions of the breast detected by mammography: review of 1182 consecutive histologically confirmed cases. Eur J Cancer 1994; 30A:40-4.
  • 13
    Lin PP, Allison DC, Wainstock J, Miller KD, Dooley WC, Friedman N, et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993; 11:1536-44.
  • 14
    Wilhelm MC, Edge SB, Cole DD, DeParedes E, Frierson HF. Nonpalpable invasive breast cancer. Ann Surg 1991; 213:600-5.
  • 15
    Schwartz GF, Feig SA, Rosenberg AL, Patchefsky AS, Schwartz AB. Staging and treatment of clinically occult breast cancer. Cancer 1984; 53:1379-84.
  • 16
    Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer 1994;73:664-7.
  • 17
    American Joint Committee on Cancer. American Joint Committee on Cancer manual for staging of cancer. 4th edition. Philadelphia: J.B. Lippincott Co., 1992.
  • 18
    Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981; 152:765-72.
  • 19
    Kiricuta CI, Tausch J, Math D. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 1992; 69:2496-501.
  • 20
    Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur J Cancer 1992; 28A:1415-8.
  • 21
    American Joint Committee on Cancer. American Joint Committee on Cancer cancer staging manual. 5th edition. Philadelphia: Lippincott-Raven, 1997.
  • 22
    Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW, Stewert HJ. Infiltrating lobular carcinoma of the breast: an evaluation of the incidence and consequence of bilateral disease. Br J Surg 1983; 70:513-6.
  • 23
    Lesser ML, Rosen PP, Kinne DW. Multicentricity and bilaterality in invasive breast carcinoma. Surgery 1982; 91:234-40.
  • 24
    Rosen PP. Invasive mammary carcinoma. In: HarrisJR, LippmanME, MorrowM, HellmanS, editors. Diseases of the breast. Philadelphia: Lippincott-Raven, 1996:420-1.
  • 25
    Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312:674-81.
  • 26
    Mustafa IA, Cole B, Wanebo HJ, Bland KI, Chang HR. The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg 1997; 132:384-91.
  • 27
    Feigelson BJ, Acosta JA, Feigelson HS, Findley A, Saunders EL. T1 breast carcinoma in women 70 years of age and older may not require axillary lymph node dissection. Am J Surg 1996; 172:487-90.
  • 28
    Cady B, Stone MD, Wayne J. New therapeutic possibilities in primary invasive breast cancer. Ann Surg 1993; 218:338-49.
  • 29
    Margolese RG, Foster RS. Tamoxifen as an alternative to surgical resection for selected geriatric patients with primary breast cancer. Arch Surg 1989; 124:548-51.
  • 30
    Craig PH, Silverstein MJ. Small invasive carcinomas: the role of axillary lymph node dissection. In: BlandKI, Copeland, EM, editors. The breast: comprehensive management of benign and malignant diseases. 2nd edition. Philadelphia: W.B. Saunders, 1998:107293.
  • 31
    McDivitt RW, Boyce W, Gersell D. Tubular carcinoma of the breast. Clinical and pathological observations concerning 135 cases. Am J Surg Pathol 1982;6:401-11.
  • 32
    Peters GN, Wolff M, Haagensen CD. Tubular carcinoma of the breast. Clinical pathologic correlations based on 100 cases. Ann Surg 1981;193:138-49.
  • 33
    Morrow M. Role of axillary dissection in breast cancer management. Ann Surg Oncol 1996; 3:233-4.
  • 34
    Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer. A multicenter validation study. N Engl J Med 1998;339:941-6.
  • 35
    McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR, et al. Sentinel-lymph-node biopsy for breast cancer-not yet the standard of care. N Engl J Med 1998; 339:990-4.